These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Some factors influencing the bioavailability of zinc in oral pharmaceutical dosage forms]. Neve J, Hanocq M, Peretz A, Abi Khalil F, Pelen F. J Pharm Belg; 1993; 48(1):5-11. PubMed ID: 8483101 [Abstract] [Full Text] [Related]
9. The bioavailability of oral dosage forms of a new HIV-1 protease inhibitor, KNI-272, in beagle dogs. Kiriyama A, Sugahara M, Yoshikawa Y, Kiso Y, Takada K. Biopharm Drug Dispos; 1996 Mar; 17(2):125-34. PubMed ID: 8907719 [Abstract] [Full Text] [Related]
10. Pre-clinical and clinical evaluation of solution and soft gelatin capsule formulations for a BCS class 3 compound with atypical physicochemical properties. Ramsay-Olocco K, Alexandrova L, Nellore R, Killion R, Li L, Coen P, Ho Q, Jung D, Rocha C. J Pharm Sci; 2004 Sep; 93(9):2214-21. PubMed ID: 15295782 [Abstract] [Full Text] [Related]
12. Challenges of Dissolution Methods Development for Soft Gelatin Capsules. Damian F, Harati M, Schwartzenhauer J, Van Cauwenberghe O, Wettig SD. Pharmaceutics; 2021 Feb 04; 13(2):. PubMed ID: 33557167 [Abstract] [Full Text] [Related]
13. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. Kuentz M, Nick S, Parrott N, Röthlisberger D. Eur J Pharm Sci; 2006 Jan 04; 27(1):91-9. PubMed ID: 16219449 [Abstract] [Full Text] [Related]